Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYDROCHLOROTHIAZIDE Cause Eye pain? 269 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 269 reports of Eye pain have been filed in association with HYDROCHLOROTHIAZIDE (Irbesartan and Hydrochlorothiazide). This represents 1.3% of all adverse event reports for HYDROCHLOROTHIAZIDE.

269
Reports of Eye pain with HYDROCHLOROTHIAZIDE
1.3%
of all HYDROCHLOROTHIAZIDE reports
210
Deaths
9
Hospitalizations

How Dangerous Is Eye pain From HYDROCHLOROTHIAZIDE?

Of the 269 reports, 210 (78.1%) resulted in death, 9 (3.3%) required hospitalization, and 6 (2.2%) were considered life-threatening.

Is Eye pain Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYDROCHLOROTHIAZIDE. However, 269 reports have been filed with the FAERS database.

What Other Side Effects Does HYDROCHLOROTHIAZIDE Cause?

Hyponatraemia (2,138) Drug ineffective (1,889) Acute kidney injury (1,838) Nausea (1,536) Dyspnoea (1,521) Dizziness (1,469) Headache (1,419) Hypotension (1,347) Fall (1,323) Malaise (1,312)

What Other Drugs Cause Eye pain?

CENEGERMIN-BKBJ (5,847) DUPILUMAB (2,599) CYCLOSPORINE (2,197) ADALIMUMAB (1,160) AFLIBERCEPT (1,057) LIFITEGRAST (1,032) ETANERCEPT (747) FINGOLIMOD (689) LATANOPROST (668) RANIBIZUMAB (632)

Which HYDROCHLOROTHIAZIDE Alternatives Have Lower Eye pain Risk?

HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\IRBESARTAN HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LISINOPRIL HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LOSARTAN HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\METOPROLOL HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\NEBIVOLOL

Related Pages

HYDROCHLOROTHIAZIDE Full Profile All Eye pain Reports All Drugs Causing Eye pain HYDROCHLOROTHIAZIDE Demographics